Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan Morote

Showing results (41-50 of 196) with videos related to

Pageof 20
Sort By:
Clinical Genitourinary Cancer|January 9, 2020
Assessing the Clinical Benefit of UBC Rapid in the Surveillance and Initial Diagnosis of Bladder CancerFernando Agreda Castañeda, Carles Xavier Raventós Busquets, Juan Morote Robles
Urologia Internationalis|May 18, 2005
Gastric cancer in augmentation gastrocystoplastySalvador Esquena Fernández, José María Abascal, Edmundo Tremps, et al.
Environmental and Molecular Mutagenesis|October 5, 2018
Micronuclei frequency in urothelial cells of bladder cancer patients, as a biomarker of prognosisFelicidad Espinoza, Lluis Cecchini, Juan Morote, et al.
International Journal of Cancer|January 9, 2004
Nadir prostate-specific antigen best predicts the progression to androgen-independent prostate cancerJuan Morote, Enrique Trilla, Salvador Esquena, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 5, 2016
Behavior of chemiluminescent assays to measure serum testosterone during androgen deprivation therapyJuan Morote, Inma Comas, Jacques Planas, et al.
Molecular Diagnosis & Therapy|April 26, 2022
Proclarix, A New Biomarker for the Diagnosis of Clinically Significant Prostate Cancer: A Systematic ReviewMíriam Campistol, Juan Morote, Lucas Regis, et al.
Journal of Biomedical Science|October 24, 2017
Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patientsJuan Morote, Imma Comas, Roser Ferrer, et al.
European Urology Open Science|July 7, 2022
The True Utility of Predictive Models Based on Magnetic Resonance Imaging in Selecting Candidates for Prostate BiopsyJuan Morote, Ángel Borque-Fernando, Marina Triquell, et al.
Current Urology|April 21, 2025
A review of the Moses effect and its applications in endourologyAdrià Piñero, Alonso Narváez, José Placer, et al.
Actas Urologicas Espanolas|May 26, 2009
[Kidney pelvis bifida]Cristóbal Ramírez Sevilla, Edmundo Tremps Velázquez, Esther Gómez Lanza, et al.
Pageof 20

Showing results (41-50 of 196) with videos related to

Sort By:
Pageof 20
Clinical Genitourinary Cancer|January 9, 2020
Assessing the Clinical Benefit of UBC Rapid in the Surveillance and Initial Diagnosis of Bladder CancerFernando Agreda Castañeda, Carles Xavier Raventós Busquets, Juan Morote Robles
Urologia Internationalis|May 18, 2005
Gastric cancer in augmentation gastrocystoplastySalvador Esquena Fernández, José María Abascal, Edmundo Tremps, et al.
Environmental and Molecular Mutagenesis|October 5, 2018
Micronuclei frequency in urothelial cells of bladder cancer patients, as a biomarker of prognosisFelicidad Espinoza, Lluis Cecchini, Juan Morote, et al.
International Journal of Cancer|January 9, 2004
Nadir prostate-specific antigen best predicts the progression to androgen-independent prostate cancerJuan Morote, Enrique Trilla, Salvador Esquena, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 5, 2016
Behavior of chemiluminescent assays to measure serum testosterone during androgen deprivation therapyJuan Morote, Inma Comas, Jacques Planas, et al.
Molecular Diagnosis & Therapy|April 26, 2022
Proclarix, A New Biomarker for the Diagnosis of Clinically Significant Prostate Cancer: A Systematic ReviewMíriam Campistol, Juan Morote, Lucas Regis, et al.
Journal of Biomedical Science|October 24, 2017
Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patientsJuan Morote, Imma Comas, Roser Ferrer, et al.
European Urology Open Science|July 7, 2022
The True Utility of Predictive Models Based on Magnetic Resonance Imaging in Selecting Candidates for Prostate BiopsyJuan Morote, Ángel Borque-Fernando, Marina Triquell, et al.
Current Urology|April 21, 2025
A review of the Moses effect and its applications in endourologyAdrià Piñero, Alonso Narváez, José Placer, et al.
Actas Urologicas Espanolas|May 26, 2009
[Kidney pelvis bifida]Cristóbal Ramírez Sevilla, Edmundo Tremps Velázquez, Esther Gómez Lanza, et al.
Pageof 20